MAGEA1 and neoplasm: The tumor volume (Fig. 8d), weight (Fig. 8e), and morphology (Fig. 8f) further confirmed that mCART can specifically target and significantly inhibit MAGE-A1-positive LUAD xenograft growth in vivo.